Markston International LLC lowered its position in shares of Monsanto Company (NYSE:MON) by 7.2% during the third quarter, Holdings Channel reports. The fund owned 114,785 shares of the company’s stock after selling 8,915 shares during the period. Markston International LLC’s holdings in Monsanto Company were worth $11,731,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in MON. WFG Advisors LP boosted its position in Monsanto Company by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the period. Signaturefd LLC boosted its position in Monsanto Company by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC boosted its position in Monsanto Company by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC boosted its position in Monsanto Company by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the period. Finally, Enterprise Financial Services Corp boosted its position in Monsanto Company by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock worth $138,000 after buying an additional 57 shares during the period. Hedge funds and other institutional investors own 74.72% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded up 1.19% during midday trading on Wednesday, hitting $110.14. The company had a trading volume of 639,718 shares. The firm’s 50 day moving average is $106.29 and its 200 day moving average is $104.26. Monsanto Company has a 52 week low of $83.73 and a 52 week high of $114.26. The company has a market capitalization of $48.30 billion, a P/E ratio of 30.20 and a beta of 1.01.
Monsanto Company (NYSE:MON) last issued its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.20. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The firm earned $2.22 billion during the quarter. During the same period last year, the firm earned ($0.11) EPS. The company’s revenue for the quarter was up 19.4% on a year-over-year basis. Equities research analysts anticipate that Monsanto Company will post $4.73 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, January 6th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.98%. The ex-dividend date is Wednesday, January 4th. Monsanto Company’s dividend payout ratio (DPR) is currently 58.86%.
MON has been the subject of a number of research analyst reports. Goldman Sachs Group, Inc. (The) raised Monsanto Company from a “sell” rating to a “neutral” rating and set a $104.00 price target for the company in a report on Tuesday, September 27th. Monness Crespi & Hardt lowered their price target on Monsanto Company from $130.00 to $128.00 and set a “buy” rating for the company in a report on Monday, October 3rd. Barclays PLC reissued a “hold” rating and set a $110.00 price target on shares of Monsanto Company in a report on Thursday, October 6th. Deutsche Bank AG reissued a “buy” rating on shares of Monsanto Company in a report on Thursday, October 6th. Finally, Zacks Investment Research cut Monsanto Company from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and seventeen have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $114.46.
In other Monsanto Company news, EVP Kerry J. Preete sold 2,745 shares of Monsanto Company stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the sale, the executive vice president now owns 50,056 shares of the company’s stock, valued at $5,053,653.76. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Steven Mizell sold 2,525 shares of Monsanto Company stock in a transaction dated Tuesday, January 10th. The stock was sold at an average price of $108.56, for a total value of $274,114.00. Following the sale, the executive vice president now directly owns 43,711 shares of the company’s stock, valued at approximately $4,745,266.16. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.
About Monsanto Company
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).